IL148549A0 - Subunit optimized fusion proteins - Google Patents
Subunit optimized fusion proteinsInfo
- Publication number
- IL148549A0 IL148549A0 IL14854900A IL14854900A IL148549A0 IL 148549 A0 IL148549 A0 IL 148549A0 IL 14854900 A IL14854900 A IL 14854900A IL 14854900 A IL14854900 A IL 14854900A IL 148549 A0 IL148549 A0 IL 148549A0
- Authority
- IL
- Israel
- Prior art keywords
- subunit
- fusion proteins
- optimized fusion
- optimized
- proteins
- Prior art date
Links
- 102000037865 fusion proteins Human genes 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01031—Beta-glucuronidase (3.2.1.31)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39907999A | 1999-09-17 | 1999-09-17 | |
PCT/US2000/025558 WO2001019842A1 (en) | 1999-09-17 | 2000-09-18 | Subunit optimized fusion proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148549A0 true IL148549A0 (en) | 2002-09-12 |
Family
ID=23578058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14854900A IL148549A0 (en) | 1999-09-17 | 2000-09-18 | Subunit optimized fusion proteins |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1237900A4 (en) |
JP (1) | JP2003509038A (en) |
KR (1) | KR20020039346A (en) |
CN (1) | CN1379782A (en) |
AU (1) | AU781462B2 (en) |
BR (1) | BR0014524A (en) |
CA (1) | CA2384766A1 (en) |
HU (1) | HUP0202702A2 (en) |
IL (1) | IL148549A0 (en) |
MX (1) | MXPA02002768A (en) |
NO (1) | NO20021244L (en) |
NZ (1) | NZ517774A (en) |
RU (1) | RU2002110116A (en) |
WO (1) | WO2001019842A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030035798A1 (en) | 2000-08-16 | 2003-02-20 | Fang Fang | Humanized antibodies |
JP2005522192A (en) | 2001-07-19 | 2005-07-28 | パーラン セラピューティクス, インコーポレイテッド | Multimeric proteins and methods of making and using multimeric proteins |
SG11201603360QA (en) * | 2013-11-19 | 2016-05-30 | Regeneron Pharma | Non-human animals having a humanized b-cell activating factor gene |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL111748A0 (en) * | 1993-12-03 | 1995-01-24 | Zeneca Ltd | Proteins |
GB9406974D0 (en) * | 1994-04-08 | 1994-06-01 | Pharmaceutical Proteins Ltd | Transgenic production |
US5959171A (en) * | 1994-08-17 | 1999-09-28 | Pharming B.V. | Method for the production of biologically active polypeptides in a mammal's |
US5635363A (en) * | 1995-02-28 | 1997-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
AU6184298A (en) * | 1997-02-25 | 1998-09-09 | Genzyme Transgenics Corporation | Transgenically produced non-secreted proteins |
GB9708918D0 (en) * | 1997-05-01 | 1997-06-25 | Ppl Therapeutics Scotland Ltd | Methods |
JP4087563B2 (en) * | 1998-06-15 | 2008-05-21 | ジーティーシー バイオセラピューティックス インコーポレイテッド | Erythropoietin analog-human serum albumin fusion |
-
2000
- 2000-09-18 KR KR1020027003537A patent/KR20020039346A/en not_active Application Discontinuation
- 2000-09-18 NZ NZ517774A patent/NZ517774A/en unknown
- 2000-09-18 MX MXPA02002768A patent/MXPA02002768A/en unknown
- 2000-09-18 EP EP00963585A patent/EP1237900A4/en not_active Withdrawn
- 2000-09-18 HU HU0202702A patent/HUP0202702A2/en unknown
- 2000-09-18 IL IL14854900A patent/IL148549A0/en unknown
- 2000-09-18 WO PCT/US2000/025558 patent/WO2001019842A1/en not_active Application Discontinuation
- 2000-09-18 CN CN00814422A patent/CN1379782A/en active Pending
- 2000-09-18 RU RU2002110116/13A patent/RU2002110116A/en unknown
- 2000-09-18 BR BR0014524-6A patent/BR0014524A/en not_active IP Right Cessation
- 2000-09-18 AU AU38831/01A patent/AU781462B2/en not_active Ceased
- 2000-09-18 JP JP2001523619A patent/JP2003509038A/en active Pending
- 2000-09-18 CA CA002384766A patent/CA2384766A1/en not_active Abandoned
-
2002
- 2002-03-13 NO NO20021244A patent/NO20021244L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1237900A1 (en) | 2002-09-11 |
CA2384766A1 (en) | 2001-03-22 |
HUP0202702A2 (en) | 2002-12-28 |
EP1237900A4 (en) | 2005-08-03 |
KR20020039346A (en) | 2002-05-25 |
NZ517774A (en) | 2005-01-28 |
NO20021244D0 (en) | 2002-03-13 |
MXPA02002768A (en) | 2002-08-30 |
RU2002110116A (en) | 2004-03-10 |
BR0014524A (en) | 2002-06-11 |
AU781462B2 (en) | 2005-05-26 |
JP2003509038A (en) | 2003-03-11 |
WO2001019842A9 (en) | 2002-11-14 |
WO2001019842A1 (en) | 2001-03-22 |
AU3883101A (en) | 2001-04-17 |
CN1379782A (en) | 2002-11-13 |
NO20021244L (en) | 2002-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302529A3 (en) | Glp-1 fusion proteins | |
IL147109A0 (en) | Substtituted heterocycle fused gamma-carbolines | |
EP1274720A4 (en) | Albumin fusion proteins | |
GB9718609D0 (en) | Fusion protein | |
AU2001291049A1 (en) | Defensin-antigen fusion proteins | |
GB9913437D0 (en) | Fusion proteins | |
GB9921125D0 (en) | Proteins | |
GB2353080B (en) | Joint | |
IL148550A0 (en) | Transgenically produced fusion proteins | |
EP1198474A4 (en) | Uncoupling proteins | |
GB9912337D0 (en) | Mechanical joint | |
IL148549A0 (en) | Subunit optimized fusion proteins | |
GB9903430D0 (en) | Novel proteins | |
GB9927681D0 (en) | Protein | |
IL149202A0 (en) | Hedgehog fusion proteins and uses | |
IL150134A0 (en) | Apoptin-associating protein | |
EP1146053A4 (en) | Meg-4 protein | |
HK1045173A1 (en) | Polypeptide | |
GB0112374D0 (en) | Novel protein | |
GB2364057A8 (en) | G protein coupled receptor | |
EP1209231A4 (en) | Meg-1 protein | |
GB9924060D0 (en) | VIP54 protein | |
EP1188828A4 (en) | Reg-binding protein | |
GB9918680D0 (en) | Polypeptide | |
GB9907114D0 (en) | Proteins |